LTR Pharma Limited (AU:LTP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited has requested a trading halt on its securities ahead of a significant announcement regarding a capital raise. The halt will remain in place until either the announcement is made or trading resumes on December 10, 2024. This move could signal potential growth opportunities for the company, which is focused on innovative treatments for men’s health.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.